NASDAQ: ALEC - Alector, Inc.

Yield per half year: +9.04%
Sector: Healthcare

Share chart Alector, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

Alector, Inc., биофармацевтическая компания клинической стадии, разрабатывает методы лечения нейродегенеративных заболеваний. Его продукты включают AL001, гуманизированное рекомбинантное моноклональное антитело, которое проходит фазу II клинических испытаний для лечения лобно-височной деменции; и AL101, который проходит фазу I клинических испытаний для лечения нейродегенеративных заболеваний, включая болезни Альцгеймера и Паркинсона. Компания также предлагает AL002 и AL003, которые находятся на фазе 1b клинических испытаний для лечения болезни Альцгеймера.

More details
Кроме того, у него есть 10 программ на стадии исследований и разработок. Компания заключила соглашение о сотрудничестве с Adimab, LLC в области исследования и разработки антител. Компания Alector, Inc. была основана в 2013 году, ее штаб-квартира находится в Южном Сан-Франциско, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

P/S 47.28
P/BV 5.15
EV/EBITDA -8.84
EBITDA -0.1088
Цена ао 5.55
Сайт http://www.alector.com
Число акций ао 0.08373 млрд
Выручка 0.0212
Див.доход ао 0
P/E 18.21
ISIN US0144421072
Валюта usd
IPO date 2019-02-07
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: 0% (5.55)
Change price per week: +19.87% (4.63)
Change price per month: -7.96% (6.03)
Change price per 3 month: -4.8% (5.83)
Change price per half year: +9.04% (5.09)
Change price per year: -8.11% (6.04)
Change price per 3 year: -78.5% (25.81)
Change price per 5 year: -61.42% (14.385)
Change price per year to date: 0% (5.55)
All parameters

Underestimation

Title Value Grade
P/S 6.9 1
P/BV 4.99 3
P/E 18.21 7
EV/EBITDA -4.44 0
Total: 5.13

Efficiency

Title Value Grade
ROA, % -20.97 0
ROE, % -97.19 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.2724 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 357.84 10
Yield Ebitda, % 24.91 4
Yield EPS, % 5.93 1
Total: 5.8
More

Transaction date Date of disclosure Insider Type Price Volume Quantity Share before, % Share after, % Document
12.08.2024 13.08.2024 Yaffe Kristine
Director		 Sale 5.06 25 300 5000 0 -0.01 link
12.08.2024 13.08.2024 Hammond Paula
Director		 Sale 5.06 53 130 10500 0 -0.01 link
04.12.2023 06.12.2023 Kenkare-Mitra Sara
President and Head of R&D		 Sale 5.56 69 606 12519 0 -0.02 link
04.12.2023 06.12.2023 Rosenthal Arnon
Chief Executive Officer		 Sale 5.56 132 500 23831 0 -0.03 link
05.09.2023 06.09.2023 GRASSO MARC
Chief Financial Officer		 Sale 5.19 5 782 1114 0 0 link
10.09.2022 31.01.2023 Yaffe Kristine
Director		 Purchase 18.1 36 200 2000 0 0 link

Institutions Volume Share, %
FMR, LLC 12620404 13.18
Blackrock Inc. 8068553 8.43
Morgan Stanley 4650191 4.86
Vanguard Group Inc 4386541 4.58
EcoR1 Capital, LLC 4056548 4.24
Braidwell LP 3324308 3.47
State Street Corporation 3117529 3.26
Deutsche Bank Aktiengesellschaft 2062099 2.15
JP Morgan Chase & Company 1863998 1.95
Geode Capital Management, LLC 1381786 1.44

ETF Share, % Profitability for 1 year, % Dividends, %
Global X Aging Population ETF 0.26261 26.771653543307 1.46713
Avantis U.S Small Cap Equity ETF 0.01786 35.517080018718 1.68271
Avantis U.S. Equity ETF 0.00141 37.016870113839 1.59151
Virtus LifeSci Biotech Clinical Trials ETF 0.92379 77.329244365683 0.33
ProShares Ultra Nasdaq Biotechnology 0.03612 58.954326923077 0.85651
ProShares UltraShort Nasdaq Biotechnology 0.18 -43.384373773066 1.76
Dimensional U.S. Core Equity 2 ETF 0.00033 37.528779739064 1.47098
Dimensional US Core Equity Market ETF 0.00073 35.65815324165 1.40618
Dimensional U.S. Equity ETF 0.0005 36.134982184029 1.3557
iShares ESG Aware MSCI USA Small-Cap ETF 0.05287 39.294631710362 1.49366
Fidelity MSCI Health Care Index ETF 0.00603 21.181088923024 1.46057
ProShares Hedge Replication ETF 0.00277 6.8665973306333 1.47892
Humankind US Stock ETF 0.00375 22.971795629061 1.99919
Invesco Nasdaq Biotechnology ETF 0.05703 29.399255715045 0.8565
iShares Neuroscience and Healthcare ETF 0.81486 20.843202273804 0.03
iShares Morningstar Small-Cap ETF 0.00937 37.681332167863 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00748 41.553945249597 0.72598
iShares Morningstar Small Cap Value ETF 0.01066 40.493824576094 2.50476
iShares Micro-Cap ETF 0.11775 43.316995205115 1.54048
iShares Russell 2000 Growth ETF 0.03434 47.42032299557 0.6026
iShares Russell 3000 ETF 0.00063 37.942616648456 1.43482
iShares Morningstar Small-Cap ETF 0.00937 410.50632631881 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00748 757.51743375174 0.72598
iShares Morningstar Small-Cap Value ETF 0.01066 252.86210418795 2.50476
Direxion Daily S&P Biotech Bull 3x Shares 0.04782 5201.8382352941 0.25924
Nuveen ESG Small-Cap ETF 0.02612 36.100211288862 1.41019
Schwab U.S. Small-Cap ETF 0.01072 -30.367553865653 1.51433
Schwab U.S. Broad Market ETF 0.00048 -53.970149253731 1.43354
SPDR Portfolio MSCI Global Stock Market ETF 0.00425 29.55850326668 2.19607
ProShares UltraPro Russell2000 0.01003 125.96465921385 1.47873
Vanguard Russell 3000 ETF 0 38.467141890837 1.43817
Vanguard Russell 2000 Growth ETF 0.03 46.764050831914 0.60264
Vanguard Russell 2000 ETF 0.02 41.410408042578 1.48801
Principal Healthcare Innovators ETF 0.05663 631.79771324797 0.8416
Future Tech ETF 0.05663 412.888593871 0.8416



Head Job title Payment Year of birth
Dr. Marc Grasso M.D. CFO, Principal Financial Officer & Principal Accounting Officer 738.05k 1974 (50 years)
Ms. Clare Hunt M.B.A. Chief People Officer N/A
Dr. Arnon Rosenthal Ph.D. Co-Founder, CEO & Director 1.02M 1956 (68 years)
Ms. Danielle Pasqualone J.D., Ph.D. General Counsel N/A
Mr. Peter Heutink Ph.D. Chief Scientific Officer N/A
Ms. Kristina Cutter M.P.H. Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer N/A
Dr. Gary Romano M.D., Ph.D. Chief Medical Officer 602.98k 1962 (62 years)
Ms. Virginia DeJesus-Rueff M.B.A. Chief of Staff & Head of Strategy N/A
Dr. Saraswati Kenkare-Mitra Ph.D. President and Head of Research & Development 1968 (56 years)
Ms. Katie Hogan Senior Director of Corporate Communication & Investor Relations

Address: United States, South San Francisco, CA , 131 Oyster Point Boulevard - open in Google maps, open in Yandex maps
Website: http://www.alector.com